Glazer Capital LLC
TLSIW icon

Glazer Capital LLC’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Glazer Capital LLC’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-794
Closed -$1K – 860
2021
Q3 		$1K Sell
794
-17,396
-96% -$16.1K ﹤0.01% 925
2021
Q2 		$19K Buy
+18,190
New +$17.9K ﹤0.01% 897

Other funds holding TLSIW

Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Angelo Gordon & Co
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Governors Lane
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Glazer Capital LLC's TLSIW Position: Q4 2021 in Review

Glazer Capital LLC sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2021, closing a stake of 794 shares — an estimated $1K sold.

Glazer Capital LLC first reported a position in TLSIW in Q2 2021 and held it in 2 quarters. The position peaked at $19K in Q2 2021. 30 funds tracked by Wall St. Rank hold TLSIW as of Q4 2021.

  • Glazer Capital LLC reported no remaining TriSalus Life Sciences Warrant position as of Q4 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 794 TriSalus Life Sciences Warrant shares in Q4 2021, an estimated $1K.
  • Glazer Capital LLC first reported a position in TriSalus Life Sciences Warrant in Q2 2021 and held it in 2 quarters.
  • Glazer Capital LLC's TriSalus Life Sciences Warrant position peaked at $19K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2021.

Based on Glazer Capital LLC's 13F filing for Q4 2021, filed 14 Feb 2022.